Affimed N.V. - stock earnings
AFMD Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 28, 2024 BeforeMarket | - / -1.8600000000 | - | - / 1.2 million | - |
AFMD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -25.8 million USD | 2.1 million USD |
| 2023Q2 | -32.0 million USD | 1.5 million USD |
| 2023Q1 | -34.9 million USD | 4.9 million USD |
| 2022Q4 | -39.4 million USD | 12.0 million USD |
| 2022Q3 | -13.5 million USD | 14.6 million USD |
| 2022Q2 | -17.9 million USD | 7.6 million USD |
| 2022Q1 | -18.6 million USD | 8.9 million USD |
| 2021Q4 | -26.3 million USD | 11.8 million USD |
| 2021Q3 | -19.8 million USD | 10.0 million USD |
| 2021Q2 | -22.2 million USD | 11.5 million USD |
| 2021Q1 | -17.4 million USD | 11.4 million USD |
| 2020Q4 | -18.1 million USD | 11.9 million USD |
| 2020Q3 | -7.0 million USD | 12.4 million USD |
| 2020Q2 | -13.7 million USD | 3.3 million USD |
| 2020Q1 | -14.3 million USD | 4.3 million USD |
| 2019Q4 | -14.6 million USD | 4.4 million USD |
| 2019Q3 | -11.9 million USD | 2.3 million USD |
| 2019Q2 | -11.8 million USD | 4.6 million USD |
| 2019Q1 | 2.1 million USD | 12.7 million USD |
| 2018Q4 | 10.0 million USD | 26.0 million USD |
| 2018Q3 | -14.0 million USD | 356092 USD |
| 2018Q2 | -9.3 million USD | 173445 USD |
| 2018Q1 | -10.1 million USD | 654519 USD |
| 2017Q4 | -7.7 million USD | 759510 USD |
| 2017Q3 | -9.5 million USD | 550219 USD |
| 2017Q2 | -9.1 million USD | 581253 USD |
| 2017Q1 | -8.3 million USD | 426411 USD |
| 2016Q4 | -5.7 million USD | 1.4 million USD |
| 2016Q3 | -11.6 million USD | 1.1 million USD |
| 2016Q2 | -8.9 million USD | 2.3 million USD |
| 2016Q1 | -9.6 million USD | 2.2 million USD |
| 2015Q4 | -6.9 million USD | 1.8 million USD |
| 2015Q3 | -8.2 million USD | 1.3 million USD |
| 2015Q2 | -5.8 million USD | 2.5 million USD |
| 2015Q1 | -1.6 million USD | 2.7 million USD |
| 2014Q4 | -6.4 million USD | 98512 USD |
| 2014Q3 | 9.3 million USD | 2.4 million USD |
| 2014Q2 | 18.2 million USD | 937342 USD |
| 2014Q1 | -21.5 million USD | 992894 USD |
| 2013Q4 | -3.5 million USD | 6.4 million USD |
| 2013Q3 | -15.6 million USD | 257754 USD |
| 2013Q2 | -10.9 million USD | 262023 USD |
| 2013Q1 | -4.7 million USD | 89711 USD |
| 2012Q4 | ? USD | 2.0 million USD |
AFMD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -131.7 million USD | 21.0 million USD |
| 2022 | -92.3 million USD | 44.4 million USD |
| 2021 | -65.4 million USD | 45.9 million USD |
| 2020 | -50.4 million USD | 34.5 million USD |
| 2019 | -36.3 million USD | 24.0 million USD |
| 2018 | -22.3 million USD | 27.2 million USD |
| 2017 | -36.1 million USD | 2.4 million USD |
| 2016 | -33.9 million USD | 6.6 million USD |
| 2015 | -22.1 million USD | 8.3 million USD |
| 2014 | -314995 USD | 4.1 million USD |
| 2013 | -36.0 million USD | 7.0 million USD |
| 2012 | -18.9 million USD | 1.5 million USD |
AFMD
Price: $5.30
52 week price:
Earnings Per Share: -8.56 USD
P/E Ratio: -0.62
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.5 million
Ebitda: -9.1 millionMarket Capitalization: 93.6 million